185 related articles for article (PubMed ID: 11406895)
1. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
Sarhill N; Walsh D; Nelson KA; Homsi J; LeGrand S; Davis MP
Am J Hosp Palliat Care; 2001; 18(3):187-92. PubMed ID: 11406895
[TBL] [Abstract][Full Text] [Related]
2. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate for depression in hospice practice: a case series.
Homsi J; Walsh D; Nelson KA; LeGrand S; Davis M
Am J Hosp Palliat Care; 2000; 17(6):393-8. PubMed ID: 11886041
[TBL] [Abstract][Full Text] [Related]
4. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study.
Sugawara Y; Akechi T; Shima Y; Okuyama T; Akizuki N; Nakano T; Uchitomi Y
Palliat Med; 2002 May; 16(3):261-3. PubMed ID: 12047006
[No Abstract] [Full Text] [Related]
6. Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer.
Johnson RL; Block I; Gold MA; Markwell S; Zupancic M
Psychooncology; 2010 Sep; 19(9):955-8. PubMed ID: 19918954
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of methylphenidate for depression in advanced cancer.
Homsi J; Nelson KA; Sarhill N; Rybicki L; LeGrand SB; Davis MP; Walsh D
Am J Hosp Palliat Care; 2001; 18(6):403-7. PubMed ID: 11712722
[TBL] [Abstract][Full Text] [Related]
8. Use of methylphenidate in patients with cancer.
Sood A; Barton DL; Loprinzi CL
Am J Hosp Palliat Care; 2006; 23(1):35-40. PubMed ID: 16450661
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
[TBL] [Abstract][Full Text] [Related]
10. The use of methylphenidate to relieve fatigue.
Rojí R; Centeno C
Curr Opin Support Palliat Care; 2017 Dec; 11(4):299-305. PubMed ID: 28885263
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment options for cancer-related fatigue: current state of clinical research.
Breitbart W; Alici Y
Clin J Oncol Nurs; 2008 Oct; 12(5 Suppl):27-36. PubMed ID: 18842522
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with response to methylphenidate in advanced cancer patients.
Yennurajalingam S; Palmer JL; Chacko R; Bruera E
Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
[TBL] [Abstract][Full Text] [Related]
13. Combining objective and subjective outcomes in cancer-related fatigue: illustrations from a single case report.
Khoshknabi DS; Davis MP; Ranganathan VK; Siemionow V; Walsh D; Kirkova J; Yue GH
J Palliat Med; 2008 Jul; 11(6):829-33. PubMed ID: 18715172
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
15. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
16. Is methylphenidate an irreplaceable therapy for the fatigued cancer patient?
Vale S
J Clin Oncol; 2004 Oct; 22(19):4028; author reply 4029. PubMed ID: 15459230
[No Abstract] [Full Text] [Related]
17. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.
Moraska AR; Sood A; Dakhil SR; Sloan JA; Barton D; Atherton PJ; Suh JJ; Griffin PC; Johnson DB; Ali A; Silberstein PT; Duane SF; Loprinzi CL
J Clin Oncol; 2010 Aug; 28(23):3673-9. PubMed ID: 20625123
[TBL] [Abstract][Full Text] [Related]
18. Question 1: Is methylphenidate a useful treatment for cancer-related fatigue in children?
Sharp V; Finlay F; Kevitiyagala D
Arch Dis Child; 2013 Jan; 98(1):80-2. PubMed ID: 23255040
[No Abstract] [Full Text] [Related]
19. [Methylphenidate and cannabinoids may have a place in palliative care. Literature review and clinical experience provides evidence].
Björkhem-Bergman L; Wallin C
Lakartidningen; 2013 Aug 7-20; 110(32-33):1409-11. PubMed ID: 23980382
[No Abstract] [Full Text] [Related]
20. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
